Heparin Market Size, Share & Trends Analysis Report By Type, By Route of Administration, By Application, By End-use (Outpatient, Inpatient), By Source, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-3-68038-154-2
- Number of Pages: 111
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Heparin Type Outlook (Revenue, USD Million, 2018 - 2030)
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Heparin Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Intravenous
- Subcutaneous
- Heparin Application Outlook (Revenue, USD Million, 2018 - 2030)
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Heparin End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Outpatient
- Inpatient
- Heparin Source Outlook (Revenue, USD Million, 2018 - 2030)
- Porcine
- Bovine
- Others
- Heparin Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- North America Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- North America Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- North America Heparin Market, By End-use
- Outpatient
- Inpatient
- North America Heparin Market, By Source
- Porcine
- Bovine
- Others
- U.S.
- U.S. Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- U.S. Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- U.S. Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- U.S. Heparin Market, By End-use
- Outpatient
- Inpatient
- U.S. Heparin Market, By Source
- Porcine
- Bovine
- Others
- U.S. Heparin Market, By Type
- Canada
- Canada Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Canada Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Canada Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Canada Heparin Market, By End-use
- Outpatient
- Inpatient
- Canada Heparin Market, By Source
- Porcine
- Bovine
- Others
- Canada Heparin Market, By Type
- North America Heparin Market, By Type
- Europe
- Europe Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Europe Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Europe Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Europe Heparin Market, By End-use
- Outpatient
- Inpatient
- Europe Heparin Market, By Source
- Porcine
- Bovine
- Others
- U.K.
- U.K. Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- U.K. Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- U.K. Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- U.K. Heparin Market, By End-use
- Outpatient
- Inpatient
- U.K. Heparin Market, By Source
- Porcine
- Bovine
- Others
- U.K. Heparin Market, By Type
- Germany
- Germany Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Germany Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Germany Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Germany Heparin Market, By End-use
- Outpatient
- Inpatient
- Germany Heparin Market, By Source
- Porcine
- Bovine
- Others
- Germany Heparin Market, By Type
- France
- France Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- France Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- France Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- France Heparin Market, By End-use
- Outpatient
- Inpatient
- France Heparin Market, By Source
- Porcine
- Bovine
- Others
- France Heparin Market, By Type
- Italy
- Italy Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Italy Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Italy Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Italy Heparin Market, By End-use
- Outpatient
- Inpatient
- Italy Heparin Market, By Source
- Porcine
- Bovine
- Others
- Italy Heparin Market, By Type
- Spain
- Spain Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Spain Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Spain Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Spain Heparin Market, By End-use
- Outpatient
- Inpatient
- Spain Heparin Market, By Source
- Porcine
- Bovine
- Others
- Spain Heparin Market, By Type
- Denmark
- Denmark Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Denmark Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Denmark Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Denmark Heparin Market, By End-use
- Outpatient
- Inpatient
- Denmark Heparin Market, By Source
- Porcine
- Bovine
- Others
- Denmark Heparin Market, By Type
- Sweden
- Sweden Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Sweden Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Sweden Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Sweden Heparin Market, By End-use
- Outpatient
- Inpatient
- Sweden Heparin Market, By Source
- Porcine
- Bovine
- Others
- Sweden Heparin Market, By Type
- Norway
- Norway Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Norway Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Norway Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Norway Heparin Market, By End-use
- Outpatient
- Inpatient
- Norway Heparin Market, By Source
- Porcine
- Bovine
- Others
- Norway Heparin Market, By Type
- Europe Heparin Market, By Type
- Asia Pacific
- Asia Pacific Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Asia Pacific Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Asia Pacific Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Asia Pacific Heparin Market, By End-use
- Outpatient
- Inpatient
- Asia Pacific Heparin Market, By Source
- Porcine
- Bovine
- Others
- China
- China Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- China Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- China Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- China Heparin Market, By End-use
- Outpatient
- Inpatient
- China Heparin Market, By Source
- Porcine
- Bovine
- Others
- China Heparin Market, By Type
- Japan
- Japan Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Japan Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Japan Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Japan Heparin Market, By End-use
- Outpatient
- Inpatient
- Japan Heparin Market, By Source
- Porcine
- Bovine
- Others
- Japan Heparin Market, By Type
- India
- India Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- India Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- India Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- India Heparin Market, By End-use
- Outpatient
- Inpatient
- India Heparin Market, By Source
- Porcine
- Bovine
- Others
- India Heparin Market, By Type
- Australia
- Australia Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Australia Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Australia Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Australia Heparin Market, By End-use
- Outpatient
- Inpatient
- Australia Heparin Market, By Source
- Porcine
- Bovine
- Others
- Australia Heparin Market, By Type
- Thailand
- Thailand Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Thailand Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Thailand Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Thailand Heparin Market, By End-use
- Outpatient
- Inpatient
- Thailand Heparin Market, By Source
- Porcine
- Bovine
- Others
- Thailand Heparin Market, By Type
- South Korea
- South Korea Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- South Korea Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- South Korea Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- South Korea Heparin Market, By End-use
- Outpatient
- Inpatient
- South Korea Heparin Market, By Source
- Porcine
- Bovine
- Others
- South Korea Heparin Market, By Type
- Asia Pacific Heparin Market, By Type
- Latin America
- Latin America Heparin Market, By Country
- Brazil
- Mexico
- Argentina
- Latin America Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Latin America Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Latin America Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Latin America Heparin Market, By End-use
- Outpatient
- Inpatient
- Latin America Heparin Market, By Source
- Porcine
- Bovine
- Others
- Brazil
- Brazil Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Brazil Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Brazil Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Brazil Heparin Market, By Application
- Outpatient
- Inpatient
- Brazil Heparin Market, By Source
- Porcine
- Bovine
- Others
- Brazil Heparin Market, By Type
- Mexico
- Mexico Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Mexico Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Mexico Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Mexico Heparin Market, By End-use
- Outpatient
- Inpatient
- Mexico Heparin Market, By Source
- Porcine
- Bovine
- Others
- Mexico Heparin Market, By Type
- Argentina
- Argentina Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Argentina Heparin Market, By Routes of Administration,
- Intravenous
- Subcutaneous
- Argentina Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Argentina Heparin Market, By End-use
- Outpatient
- Inpatient
- Argentina Heparin Market, By Source
- Porcine
- Bovine
- Others
- Argentina Heparin Market, By Type
- Latin America Heparin Market, By Country
- Middle East & Africa
- Middle East & Africa Heparin Market, By Country
- South Africa
- Saudi Arabia
- UAE
- Middle East & Africa Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Middle East & Africa Heparin Market, By Routes of Administration,
- Intravenous
- Subcutaneous
- Middle East & Africa Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Middle East & Africa Heparin Market, By End-use
- Outpatient
- Inpatient
- Middle East & Africa Heparin Market, By Source
- Porcine
- Bovine
- Others
- South Africa
- South Africa Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- South Africa Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- South Africa Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- South Africa Heparin Market, By End-use
- Outpatient
- Inpatient
- South Africa Heparin Market, By Source
- Porcine
- Bovine
- Others
- South Africa Heparin Market, By Type
- Saudi Arabia
- Saudi Arabia Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Saudi Arabia Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Saudi Arabia Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Saudi Arabia Heparin Market, By End-use
- Outpatient
- Inpatient
- Saudi Arabia Heparin Market, By Source
- Porcine
- Bovine
- Others
- Saudi Arabia Heparin Market, By Type
- UAE
- UAE Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- UAE Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- UAE Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- UAE Heparin Market, By End-use
- Outpatient
- Inpatient
- UAE Heparin Market, By Source
- Porcine
- Bovine
- Others
- UAE Heparin Market, By Type
- Kuwait
- Kuwait Heparin Market, By Type
- Low Molecular Weight Heparin
- Ultra-Low Molecular Weight Heparin
- Unfractionated Heparin
- Kuwait Heparin Market, By Routes of Administration
- Intravenous
- Subcutaneous
- Kuwait Heparin Market, By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
- Kuwait Heparin Market, By End-use
- Outpatient
- Inpatient
- Kuwait Heparin Market, By Source
- Porcine
- Bovine
- Others
- Kuwait Heparin Market, By Type
- Middle East & Africa Heparin Market, By Country
- North America
Heparin Market Dynamics
Driver: Increasing Prevalence Of Chronic Diseases
Rising prevalence of chronic diseases such as deep vein thrombosis, cardiovascular disorders, pulmonary embolism, and renal diseases is considered to be one of the crucial factors driving the overall market. Poor lifestyle, improper sleep, and bad diet is responsible for such diseases. According to American Heart Association in 2016, approximately 92.1 million American adults are living with some form of cardiovascular disease which surged to 121.5 million in 2019. Moreover, coronary heart disease is one of the leading causes of death in the U.S. It was observed that heart disease accounts for 1 in 7 deaths in the U.S. According to CDC, 2.7 million to 6.1 million individuals in the U.S. suffered from atrial fibrillation, and the number is expected to increase in the coming years. These people are at a higher risk of stroke. Heparin has proven to be extremely useful in improving health of patients suffering from atrial fibrillation and acute ischemic stroke. Increasing prevalence of related diseases and rising number of patients needing treatment involving heparin are expected to boost the market growth.
Driver: Increasing Geriatric Population
Growing number of geriatric population is expected to drive market growth.The number of people aged 60 and above has substantially increased in the recent years in most regions and this growth is expected to accelerate in the following years. Aging is considered one of the greatest risk factors for the development of cardiovascular and neurological diseases. Aging also weakens the immune system, increasing the patient’s susceptibility to infectious diseases, and affects crucial body functions. Furthermore, technological advancements in the field of healthcare, improved public health policies, and improvements in living conditions have increased the life span of humans. Furthermore, according to WHO, in 2020, maximum number of blood transfusions are needed in geriatric population in high-income countries.
Restraint: Risk Of Blood Transmitted Diseases And Increasing Number Of Blood Substitutes
Increasing prevalence of infectious and blood transmissible diseases is a critical factor that may restrain the market growth. Blood transfer need to be safe anddonors need to be checked before blood donation.
What Does This Report Include?
This section will provide insights into the contents included in this heparin market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Heparin market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Heparin market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
